Business
BioMarin to Participate in Upcoming Virtual Investor Conference
- Morningstar's Management Behind the Moat Conference on September 30 at 1:00pm ET SAN RAFAEL, Calif., Sept. 29, 2020 /PRNewswire/ -- BioMarin Pharmaceutical
About this update from Biomarin Pharmaceutical Inc.
[{"type":"text","content":"- Morningstar's Management Behind the Moat Conference on September 30 at 1:00pm ET\n\n\nSAN RAFAEL, Calif., Sept. 29, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Brian Mueller, Executive Vice President, Chief Financial Officer, will participate in Morningstar's Management Behind the Moat Conference on September 30, 2020 at 1:00pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.\n\n \n \n \n \n \n \n\n \nAbout BioMarin\nBioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. \nFor additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.\nContacts: \nInvestors \nMedia\nTraci McCarty\nDebra Charlesworth\nBioMarin Pharmaceutical Inc.\nBioMarin Pharmaceutical Inc.\n(415) 455-7558\n(415) 455-7451\n \n\n\n\n View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-virtual-investor-conference-301139652.html\nSOURCE BioMarin Pharmaceutical Inc.","length":6599,"tagName":"div"}]